Irma Bagdoniene: What Really Makes Us Live Longer
Irma Bagdoniene, Cardiologist specializing in Lipidology and Cardiovascular Prevention , shared a post on LinkedIn about a recent article by Diana Romenskaja-Avgul et al, published in Nature, adding:
“Can we really buy longevity? Or are we just buying expensive promises?
NADplus boosters, NMN supplements, anti aging therapies…
The longevity industry is booming. But does increasing a biomarker actually mean living longer?
A fascinating new study published in Nature Metabolism, involving 1,068 adults, challenges a popular assumption:
Whole blood NAD levels do NOT necessarily decline with age.
In healthy men, they remained stable. In healthy women, they actually increased with age!
This brings me back to LDL cholesterol.
We have decades of evidence that lowering LDL cholesterol reduces cardiovascular events. We know that cumulative LDL exposure drives atherosclerosis. And we have therapies with proven clinical benefits.
Yet we sometimes spend hundreds or thousands on longevity products while overlooking the risk factors that actually shorten our lives.
Longevity should be measured in healthy years gained, not in biomarkers improved.
What do you think? Are we investing too much in longevity trends and too little in evidence based prevention?”
Title: Whole-blood NAD levels track cardiovascular disease but not chronological age
Authors: Diana Romenskaja-Avgul, Deimantė Stakelytė, Audrius Laurynėnas, Eimantas Ramonas, Rūta Zabitaitė, Simona Cibulskė, Sigita Danilevičienė, Rapolas Danilevičius, Kristina Ratautė, Marius Dagys, Dalius Ratautas
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 17:11Ken Kuang: Why Your Calves Are Called Your “Second Heart”?
-
Nov 9, 2026, 17:07Mert Dumantepe: Key Insights From The 8th Abu Dhabi International Vascular Conference
-
Nov 9, 2026, 16:57Amrita Sarkar: Exciting Advances in Hematology and Vascular Research at 54th Annual Philadelphia Workshop
-
Nov 9, 2026, 16:47Joey Boxer Samuels: Prolonged Sitting and Vein Thrombosis
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day